
|Articles|April 5, 2011
ACC 2011 Interview on Cost Analysis Substituting Dabigatran for Warfarin
Dr. Julie Atay discusses her poster at ACC 2011 on "Cost Analysis of Substituting Dabigatran for Warfarin in an Anticoagulant Management Program."
Advertisement
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
ACIP Delayed Hepatitis B Vaccine Schedule Vote Amid Safety Controversy
2
Hereditary Ovarian Cancer Genes Found Beyond Traditionally High-Risk Groups
3
Medicaid Expansion Associated With Lower Mortality in NSCLC
4
ASH 2025 Offers Data That Could Make Novel Therapies More Accessible
5













































